Fenwick & West represented Maze Therapeutics in the offering, and Davis Polk & Wardwell represented the underwriters. Maze Therapeutics, Inc. (Nasdaq: MAZE) announced its upsized initial...
Maze Therapeutics’ $140 Million Upsized Initial Public Offering
FalconX’s Acquisition of Arbelos Markets
Fenwick & West represented Arbelos Markets in the transaction. FalconX, a leading digital asset prime broker, announced its acquisition of Arbelos Markets, a trading firm specializing...
BioAge Labs’ $238 Million Upsized Initial Public Offering
Fenwick & West represented BioAge Labs, Inc. in the offering, and Cooley represented the underwriters. BioAge Labs, Inc. (Nasdaq: BIOA), a clinical-stage biopharmaceutical company developing therapeutic...